BRPI0509690A - nim811 na isquemia cerebral e danos cerebrais e na medula espinhal - Google Patents

nim811 na isquemia cerebral e danos cerebrais e na medula espinhal

Info

Publication number
BRPI0509690A
BRPI0509690A BRPI0509690-1A BRPI0509690A BRPI0509690A BR PI0509690 A BRPI0509690 A BR PI0509690A BR PI0509690 A BRPI0509690 A BR PI0509690A BR PI0509690 A BRPI0509690 A BR PI0509690A
Authority
BR
Brazil
Prior art keywords
spinal cord
cerebral ischemia
neem811
brain damage
brain
Prior art date
Application number
BRPI0509690-1A
Other languages
English (en)
Inventor
Peter Waldmeier
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0509690A publication Critical patent/BRPI0509690A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

NIM811 NA ISQUEMIA CEREBRAL E DANOS CEREBRAIS E NA MEDULA ESPINHAL. As ciclosporinas que se ligam à ciclofilina não imunossupressoras, em particular, ¢Melle!¬ 4¬-Ciclosporina, são úteis como agentes neuroprotetores, por exemplo, na prevenção ou no tratamento da isquemia cerebral ou nos danos traumáticos cerebrais e da medula espinhal.
BRPI0509690-1A 2004-04-08 2005-04-07 nim811 na isquemia cerebral e danos cerebrais e na medula espinhal BRPI0509690A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56046504P 2004-04-08 2004-04-08
PCT/EP2005/003664 WO2005097164A2 (en) 2004-04-08 2005-04-07 Use of cyclosporins for treatment of cerebral ischemia and brain and spinal cord injury

Publications (1)

Publication Number Publication Date
BRPI0509690A true BRPI0509690A (pt) 2007-10-09

Family

ID=34967015

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0509690-1A BRPI0509690A (pt) 2004-04-08 2005-04-07 nim811 na isquemia cerebral e danos cerebrais e na medula espinhal

Country Status (10)

Country Link
US (1) US20080194470A1 (pt)
EP (1) EP1742652A2 (pt)
JP (1) JP2007532507A (pt)
KR (1) KR20070009674A (pt)
CN (1) CN1964735A (pt)
AU (1) AU2005230400A1 (pt)
BR (1) BRPI0509690A (pt)
CA (1) CA2561912A1 (pt)
RU (1) RU2006139004A (pt)
WO (1) WO2005097164A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7696166B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
US7696165B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
EP2808029A3 (en) * 2010-03-15 2015-04-01 Stealth Peptides International, Inc. Combination therapies using cyclosporine and aromatic cationic peptides
CN101843893B (zh) * 2010-05-21 2012-02-01 中国人民解放军第三军医大学 环孢素a在制备抗轮状病毒药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0484281B2 (en) * 1990-11-02 2000-11-22 Novartis AG Cyclosporins
GB9811854D0 (en) * 1998-06-02 1998-07-29 Ciba Geigy Ag Organic compounds
DE69912952T2 (de) * 1998-06-12 2004-09-02 C-Chem Ag Cyclosporine
FR2780061B1 (fr) * 1998-06-22 2001-09-07 Rhone Poulenc Rorer Sa Nouveau procede de preparation de derives de cyclosporine
US6255280B1 (en) * 1999-04-08 2001-07-03 University Of Kentucky Research Foundation Protection against traumatic brain injury
CA2408889A1 (en) * 2000-05-08 2001-11-15 David Haines Immunosuppressive compositions

Also Published As

Publication number Publication date
EP1742652A2 (en) 2007-01-17
AU2005230400A1 (en) 2005-10-20
WO2005097164A3 (en) 2006-06-01
RU2006139004A (ru) 2008-05-20
KR20070009674A (ko) 2007-01-18
CN1964735A (zh) 2007-05-16
WO2005097164A2 (en) 2005-10-20
US20080194470A1 (en) 2008-08-14
CA2561912A1 (en) 2005-10-20
JP2007532507A (ja) 2007-11-15

Similar Documents

Publication Publication Date Title
BRPI0513317A (pt) ciclosporinas para tratar doença de alzheimer
DK1419154T3 (da) Rapamycin-29-enoler
WO2006015263A3 (en) Lonidamine analogs
MXPA04001523A (es) Dialdehidos de rapamicina.
TNSN06071A1 (en) Use of modified cyclosporins for the treatment of hcv disorders
PA8503301A1 (es) Compuestos para el tratamiento de la isquemia
TNSN07240A1 (en) Compounds for flaviviridae treatment
CR9351A (es) Composiciones y metodos para aplicaicon topica y suministro transdermico de toxina botulinica
WO2006105403A3 (en) Treatment of eye disorders with sirtuin modulators
WO2008022349A3 (en) Agents for blood-brain barrier delivery
WO2006127987A3 (en) Treatment of eye disorders with sirtuin modulators
TW200637522A (en) Skin treatment articles and methods
MX2009012645A (es) Formulaciones y metodos para tratar el ojo seco.
TW200716157A (en) Pharmaceutical formulations and methods of treatment using the same
WO2006116221A3 (en) Therapeutic combinations for the treatment or prevention of psychotic disorders
IL186104A0 (en) Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer
DE602004021644D1 (de) Gyraseinhibitoren und deren verwendungen
MY147247A (en) Organic compounds and their uses
EA200602047A1 (ru) Сульфонилэтилфосфородиамидаты, предназначенные для применения при лечении рака
ITMI20041550A1 (it) Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide
HUP0303917A2 (hu) Szterin abszorpció inhibitor(ok) kombinációi vérmódosítókkal és ezek alkalmazása vaszkuláris kondíciók kezelésére
AR057643A1 (es) Lacosamida para terapia adjunta
WO2007028151A3 (en) Surgical devices and related methods thereof
BRPI0509690A (pt) nim811 na isquemia cerebral e danos cerebrais e na medula espinhal
UY29417A1 (es) Agentes endoparasiticidas

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.